アイオワ州における結腸癌の臨床試験
アイオワ州内の拠点で、結腸癌に関する10件の研究が参加者を募集しています。
アイオワ州内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他12件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- Mercy Cancer Center-West Lakes, Clive
- Mercy Medical Center - Des Moines, Des Moines
- Mercy Medical Center-West Lakes, West Des Moines
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Iowa ( Site 0074), Iowa City
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- University of Iowa Hospital and Clinics, Iowa City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Iowa - Holden Comprehensive Cancer Center, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07058012Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他17件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
- University of Iowa Hospitals & Clinics, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT05239546Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。